Multi-Drug Resistance Tuberculosis (MDR-TB) Challenges in India: A Review

被引：6

作者：

Vishwakarma, Deepak ^{[1
]}

Gaidhane, Abhay ^{[1
]}

Sahu, Sweta ^{[1
]}

Rathod, Ashwini S. ^{[1
]}

机构：

[1] Datta Meghe Inst Med Sci, Sch Epidemiol & Publ Hlth, Wardha, India

来源：

CUREUS JOURNAL OF MEDICAL SCIENCE | 2023年 / 15卷 / 12期

关键词：

mdr; india; challenges; multi-drug resistant tb; tb; -; tuberculosis; DRUG-RESISTANCE; EPIDEMIOLOGY; MANAGEMENT;

D O I：

10.7759/cureus.50222

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Tuberculosis (TB) is an increasing public health concern in India. The development of resistance to two of the most effective medications, rifampicin, and isoniazid, is the largest worldwide challenge in the management of TB. An epidemiological indicator used to evaluate the effectiveness of the TB management program is the initial medication resistance level. Our search for published papers in English using Medical Subject Heading phrases was conducted through PubMed, Google Scholar, and Scopus. We also looked through several official sources to learn the most recent information on multi-drug resistance in India. Multi-drug resistance tuberculosis is a significant risk to human health globally. Stigmatization or discrimination of those who have TB or who are impacted by it can make the disease more difficult to manage medically and socially, and it is ultimately responsible for missed opportunities for diagnosis and treatment, interruptions of care, and unsuccessful outcomes. Eliminating TB is complicated by stigma.

引用

页数：9

共 38 条

[1] Incidence of multidrug-resistant tuberculosis in urban and rural India and implications for prevention
Almeida, D
Rodrigues, C
Udwadia, ZF
Lalvani, A
Gothi, GD
Mehta, P
Mehta, A
[J]. CLINICAL INFECTIOUS DISEASES, 2003, 36 (12) : E152 - E154
[2] [Anonymous], 2011, Guidelines for programmatic management of drug-resistant tuberculosis. 2011 update
[3] Arora V. K., 2007, Indian Journal of Chest Diseases and Allied Sciences, V49, P75
[4] Multidrug-resistant tuberculosis (MDR-TB) in India: An attempt to link biosocial determinants
Atre, SR
Mistry, NF
[J]. JOURNAL OF PUBLIC HEALTH POLICY, 2005, 26 (01) : 96 - 114
[5] Issues in the management of drug resistant tuberculosis in India
Behera, D.
[J]. LUNG INDIA, 2013, 30 (04) : 269 - 272
[6] CDCTB, 2022, tuberculosis (TB)-drug-resistant TB. centers for disease control and prevention
[7] CDCTB, 2016, MDRTB factsheet
[8] High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in Western India
D'souza, Desiree T. B.
Mistry, Nerges F.
Vira, Tina S.
Dholakia, Yatin
Hoffner, Sven
Pasvol, Geoffrey
Nicol, Mark
Wilkinson, Robert J.
[J]. BMC PUBLIC HEALTH, 2009, 9
[9] PROBABILITY DISTRIBUTION OF DRUG-RESISTANT MUTANTS IN UNSELECTED POPULATIONS OF MYCOBACTERIUM-TUBERCULOSIS
DAVID, HL
[J]. APPLIED MICROBIOLOGY, 1970, 20 (05) : 810 - &
[10] Clinical management of adults and children with multidrug-resistant and extensively drug-resistant tuberculosis
Dheda, K.
Chang, K. C.
Guglielmetti, L.
Furin, J.
Schaaf, H. S.
Chesov, D.
Esmail, A.
Lange, C.
[J]. CLINICAL MICROBIOLOGY AND INFECTION, 2017, 23 (03) : 131 - 140

← 1 2 3 4 →